Xaracoll 100 mg per implant Images
Generic Name: bupivacaine
This medication has been identified as Xaracoll 100 mg per implant. It is supplied by Innocoll Pharmaceuticals Limited.
Xaracoll is used in the treatment of Postoperative Pain and belongs to the drug class local injectable anesthetics. Risk cannot be ruled out during pregnancy. Xaracoll 100 mg per implant is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Xaracoll
- Generic Name
- bupivacaine
- Strength
- 100 mg per implant
- Availability
- Prescription only
- Drug Class
- Local injectable anesthetics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Innocoll Pharmaceuticals Limited
- National Drug Code (NDC)
- 51715-0100 (Discontinued)
See also:
More about Xaracoll (bupivacaine)
- Check interactions
- Compare alternatives
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: local injectable anesthetics
Patient resources
Other brands
Marcaine, Sensorcaine, Sensorcaine-MPF, Marcaine HCl, Marcaine Spinal
Professional resources
- Xaracoll prescribing information
- Bupivacaine Hydrochloride, Bupivacaine Liposomal (Local) (AHFS Monograph)
Other brands
Marcaine, Posimir, Sensorcaine-MPF, Marcaine Spinal
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.